A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults. (academic.oup.com)

Authors: Cosgrove CA … Leav B Journal: Clinical Infectious Diseases Published: 2026-04-25 DOI: https://doi.org/10.1093/cid/ciag278